KAT2B Antikörper (N-Term)
Kurzübersicht für KAT2B Antikörper (N-Term) (ABIN6735735)
Target
Alle KAT2B Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- N-Term
-
Spezifität
- Recognizes the N-terminal domain of the transcriptional activator PCAF. This domain of PCAF contains a region that interacts with p300/CBP and it competes with the adenoviral E1A oncoprotein for binding to p300/CBP as a potential tumor suppressor.
-
Aufreinigung
- Protein G purified
-
Immunogen
-
N-terminal domain of human PCAF.
Type of Immunogen: Protein -
Isotyp
- IgG1
-
-
-
-
Applikationshinweise
-
Approved: ELISA (1:8000), WB
Usage: Suitable for use in ELISA, Western Blot. ELISA: 1:8000. -
Kommentare
-
Target Species of Antibody: Human
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- Lot specific
-
Buffer
- PBS, pH 7.2.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
-
Short term: 4°C
Long term: Add glycerol (40-50%) -20°C.
-
-
- KAT2B (K(lysine) Acetyltransferase 2B (KAT2B))
-
Andere Bezeichnung
- KAT2B / PCAF
-
Hintergrund
-
Name/Gene ID: KAT2B
Synonyms: KAT2B, CREBBP-associated factor, GCN5, Histone acetyltransferase PCAF, K(lysine) acetyltransferase 2B, Lysine acetyltransferase 2B, Histone acetylase PCAF, PCAF, p300/CBP-associated factor, CAF, GCN5L -
Gen-ID
- 8850
-
UniProt
- Q92831
-
Pathways
- p53 Signalweg, Regulation of Carbohydrate Metabolic Process
Target
-